60 related articles for article (PubMed ID: 35311230)
1. Extra-nuclear TERT counteracts oxidative stress and promotes progression in papillary thyroid carcinoma.
Muzza M; Pogliaghi G; Colombo C; Grassi ES; Carbone E; Palazzo S; Frattini F; Gazzano G; Persani L; Fugazzola L
Transl Res; 2024 Apr; 271():1-12. PubMed ID: 38670453
[TBL] [Abstract][Full Text] [Related]
2. Indeterminate Thyroid Nodules: From Cytology to Molecular Testing.
Vignali P; Macerola E; Poma AM; Sparavelli R; Basolo F
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761374
[TBL] [Abstract][Full Text] [Related]
3. Hobnail Papillary Thyroid Carcinoma, A Systematic Review and Meta-Analysis.
Spyroglou A; Kostopoulos G; Tseleni S; Toulis K; Bramis K; Mastorakos G; Konstadoulakis M; Vamvakidis K; Alexandraki KI
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681765
[TBL] [Abstract][Full Text] [Related]
4. Predictive Biomarkers in Thyroid Cancer.
Macerola E; Poma AM; Vignali P; Proietti A; Ugolini C; Torregrossa L; Basolo A; Elisei R; Santini F; Basolo F
Front Oncol; 2022; 12():901004. PubMed ID: 35600349
[TBL] [Abstract][Full Text] [Related]
5. Clinical-Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma.
Poma AM; Macerola E; Proietti A; Vignali P; Sparavelli R; Torregrossa L; Matrone A; Basolo A; Elisei R; Santini F; Ugolini C
Front Endocrinol (Lausanne); 2022; 13():842424. PubMed ID: 35311230
[TBL] [Abstract][Full Text] [Related]
6. Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.
Teng L; Deng W; Lu J; Zhang J; Ren X; Duan H; Chuai S; Duan F; Gao W; Lu T; Wu H; Liang Z
Oncotarget; 2017 Mar; 8(13):22023-22033. PubMed ID: 28423545
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid carcinoma with hobnail features showing rapid progression and therapy resistance.
De Graef A; Van Den Heede K; Meert V; Van Slycke S
Acta Chir Belg; 2021 Apr; 121(2):77-85. PubMed ID: 33550925
[TBL] [Abstract][Full Text] [Related]
8. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile.
Lubitz CC; Economopoulos KP; Pawlak AC; Lynch K; Dias-Santagata D; Faquin WC; Sadow PM
Thyroid; 2014 Jun; 24(6):958-65. PubMed ID: 24417340
[TBL] [Abstract][Full Text] [Related]
9. Hobnail cells in encapsulated papillary thyroid carcinoma: Report of 2 cases with immunohistochemical and molecular findings and literature analysis.
Agarwal S; Sadiq Q; Ortanca I
Pathol Res Pract; 2020 Mar; 216(3):152678. PubMed ID: 31740230
[TBL] [Abstract][Full Text] [Related]
10. Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes.
Steinschneider M; Pitaro J; Koren S; Mizrakli Y; Benbassat C; Muallem Kalmovich L
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771585
[TBL] [Abstract][Full Text] [Related]
11. Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis.
Donaldson LB; Yan F; Morgan PF; Kaczmar JM; Fernandes JK; Nguyen SA; Jester RL; Day TA
Endocrine; 2021 Apr; 72(1):27-39. PubMed ID: 33025563
[TBL] [Abstract][Full Text] [Related]
12. Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up.
Giani C; Torregrossa L; Piaggi P; Matrone A; Viola D; Molinaro E; Agate L; Romei C; Ugolini C; De Napoli L; Materazzi G; Basolo F; Elisei R
Endocrine; 2020 Jun; 68(3):607-616. PubMed ID: 32124258
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
